Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri… - ESC heart …, 2022 - Wiley Online Library
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
[PDF][PDF] Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri, R Wachter… - ESC, 2022 - core.ac.uk
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
[PDF][PDF] Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri, R Wachter… - ESC, 2022 - scholar.archive.org
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri… - 2022 - publikationen.sulb.uni-saarland.de
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
[HTML][HTML] Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri… - ESC Heart …, 2022 - ncbi.nlm.nih.gov
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials.
A Abdin, M Schulz, U Riemer, B Hadëri… - ESC Heart …, 2022 - opus.lib.uts.edu.au
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri… - ESC heart …, 2022 - pubmed.ncbi.nlm.nih.gov
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials.
A Abdin, M Schulz, U Riemer, B Hadëri… - ESC Heart …, 2022 - europepmc.org
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri… - ESC Heart …, 2022 - search.proquest.com
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …
[PDF][PDF] Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri, R Wachter… - ESC, 2022 - opus.lib.uts.edu.au
Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …
significant reductions in mortality and hospital admissions in patients with HF with reduced …